Benefits and risks of anthracyclines in early-stage breast cancer - Authors' reply. Braybrooke J, Bradley R, Gray R, Hills R, et al. Lancet 2024;403:1240.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Braybrooke J, Bradley R, Gray R, Hills R, et al. Benefits and risks of anthracyclines in early-stage breast cancer - Authors' reply. Lancet 2024;403:1240.
PMID: 38555133